Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-19-040428
Filing Date
2019-11-05
Accepted
2019-11-05 16:32:10
Documents
63
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q thor-10q_20190930.htm 10-Q 2167511
2 EX-10.1 thor-ex101_261.htm EX-10.1 98981
3 EX-10.2 thor-ex102_260.htm EX-10.2 44114
4 EX-10.3 thor-ex103_273.htm EX-10.3 156725
5 EX-31.1 thor-ex311_7.htm EX-31.1 7904
6 EX-31.2 thor-ex312_8.htm EX-31.2 7702
7 EX-32.1 thor-ex321_6.htm EX-32.1 8549
8 GRAPHIC gnurfavplb4a000001.jpg GRAPHIC 38832
  Complete submission text file 0001564590-19-040428.txt   6584547

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT thor-20190930.xml EX-101.INS 1222450
10 XBRL TAXONOMY EXTENSION SCHEMA thor-20190930.xsd EX-101.SCH 51412
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE thor-20190930_cal.xml EX-101.CAL 48801
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE thor-20190930_def.xml EX-101.DEF 126389
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE thor-20190930_lab.xml EX-101.LAB 338663
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE thor-20190930_pre.xml EX-101.PRE 251389
Mailing Address 11099 NORTH TORREY PINES ROAD SUITE 190 LA JOLLA CA 92037
Business Address 11099 NORTH TORREY PINES ROAD SUITE 190 LA JOLLA CA 92037 (858) 750-4700
Synthorx, Inc. (Filer) CIK: 0001609727 (see all company filings)

EIN.: 464709185 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38756 | Film No.: 191193788
SIC: 2834 Pharmaceutical Preparations